# AJUBA

## Overview
AJUBA is a gene that encodes the ajuba LIM protein, a multifunctional scaffold protein involved in various cellular processes, including cell adhesion, signal transduction, and cell cycle regulation. The ajuba LIM protein is characterized by its three tandemly arrayed LIM domains, which facilitate protein-protein interactions crucial for its role in cellular signaling pathways (Goyal1999Ajuba; Kanungo2000Ajuba). Predominantly located in the cytosol, the protein can shuttle to the nucleus, where it influences transcriptional repression and cell differentiation (Kanungo2000Ajuba). AJUBA is implicated in the regulation of the NF-κB signaling pathway and the DNA damage response, highlighting its importance in maintaining cellular homeostasis (Feng2005The; Fowler2018LIM). Clinically, mutations in the AJUBA gene have been associated with various cancers, where it can function as either a tumor suppressor or promoter, depending on the context (Zhang2017Mutations; Schleicher2021AJUBA:).

## Structure
The AJUBA protein is characterized by its unique molecular structure, which includes a 547-amino-acid sequence with a molecular weight of approximately 58 kDa. It contains three tandemly arrayed LIM domains at the C-terminus, which are highly conserved and involved in protein-protein interactions (Goyal1999Ajuba; Ayyanathan2007The). These LIM domains are organized into a double zinc finger structure, typical of LIM proteins, and are crucial for the protein's function in cellular signaling (Kanungo2000Ajuba).

The N-terminal region of AJUBA, known as the pre-LIM domain, is rich in glycine and proline residues and contains proline-rich SH3 recognition motifs, which facilitate interactions with proteins such as Grb2 (Goyal1999Ajuba). This region also includes a nuclear export signal (NES), which is involved in the nucleocytoplasmic shuttling of the protein (Kanungo2000Ajuba).

AJUBA is predominantly cytosolic but can shuttle into the nucleus, where it plays a role in transcriptional repression and cell differentiation (Ayyanathan2007The; Kanungo2000Ajuba). The protein does not localize to sites of focal adhesion or interact with the actin cytoskeleton, distinguishing it from other LIM proteins (Goyal1999Ajuba). The presence of splice variant isoforms and potential post-translational modifications, such as phosphorylation, contribute to its functional diversity (Kanungo2000Ajuba).

## Function
The AJUBA LIM protein is involved in several critical cellular processes, including cell adhesion, signal transduction, and the regulation of the cell cycle. In healthy human cells, AJUBA plays a significant role in the activation of NF-κB in response to interleukin-1 (IL-1) and tumor necrosis factor (TNF) stimulation. It enhances NF-κB activation by affecting the assembly and activity of the protein kinase Cζ/p62/TRAF6 signaling complex (Feng2005The). AJUBA also interacts with the RPA complex, specifically the RPA70 subunit, to regulate the ATR pathway, which is crucial for the DNA damage response. This interaction prevents inappropriate activation of ATR kinase, maintaining genome stability and cell survival during the S phase of the cell cycle (Fowler2018LIM; Kalan2013LIM).

AJUBA is also implicated in cell migration by influencing the localization and activation of the p130Cas-Crk-DOCK180 signaling complex, essential for Rac1 activation, a key regulator of cell motility (Pratt2005The). In the nucleus, AJUBA can induce endodermal differentiation in P19 embryonal carcinoma cells and is involved in mitotic cell cycle regulation by interacting with and activating the mitotic kinase Aurora A (Hirota2003AuroraA; Kanungo2000Ajuba).

## Clinical Significance
Mutations and alterations in the AJUBA gene have significant clinical implications in various cancers. In head and neck squamous cell carcinoma (HNSCC), AJUBA mutations are associated with increased sensitivity to cell-cycle inhibitors such as PLK1, CHK1/2, and WEE1 inhibitors. These mutations correlate with a reduction in tumor volume and increased survival in treated models, suggesting their potential as biomarkers for targeted therapy (Zhang2017Mutations). In oesophageal squamous cell carcinoma (ESCC), AJUBA mutations, particularly stop-gain and frame shift mutations in the LIM domain, are linked to better patient prognosis, indicating an oncogenic role in this context (Du2017Comprehensive).

AJUBA also plays a dual role in cancer, acting as both a tumor suppressor and promoter depending on the context. In HNSCC and cutaneous squamous cell carcinoma (cSCC), AJUBA loss-of-function mutations contribute to cancer development by potentially blocking proper Notch signaling (Schleicher2021AJUBA:). Conversely, in breast and pancreatic cancers, AJUBA acts as a co-activator, promoting cancer progression (Schleicher2021AJUBA:). These findings underscore the complex role of AJUBA in cancer biology, influencing tumor growth, metastasis, and drug resistance.

## Interactions
AJUBA, a LIM domain-containing protein, participates in various protein interactions that influence cellular processes. It acts as a scaffold protein, assembling numerous protein complexes. AJUBA interacts with Grb2 through its N-terminal pre-LIM domain, enhancing mitogen-activated protein kinase (MAPK) activity in fibroblasts and promoting meiotic maturation in Xenopus oocytes in a Grb2- and Ras-dependent manner (Goyal1999Ajuba). 

AJUBA also interacts with the p62/PKC/TRAF6 multiprotein signaling complex, playing a significant role in modulating IL-1-induced NF-κB activation. It recruits TRAF6 into this complex, enhancing its assembly and activity (Feng2005The). In the context of cell migration, AJUBA influences the localization and activity of p130Cas, a protein involved in the Rac1 signaling pathway, by interacting with its COOH-terminal domain (Pratt2005The).

In the nucleus, AJUBA functions as a corepressor for the zinc finger-protein Snail, recruiting Prmt5 to repress Snail target genes. It also modulates retinoic acid receptor signaling by interacting with RARα, RARγ, RXRγ, and THRα in a ligand-dependent manner (Hou2010LIM). AJUBA's interaction with the RPA complex, specifically the RPA70 subunit, suggests a role in DNA replication processes (Fowler2018LIM).


## References


[1. (Du2017Comprehensive) Peina Du, Peide Huang, Xuanlin Huang, Xiangchun Li, Zhimin Feng, Fengyu Li, Shaoguang Liang, Yongmei Song, Jan Stenvang, Nils Brünner, Huanming Yang, Yunwei Ou, Qiang Gao, and Lin Li. Comprehensive genomic analysis of oesophageal squamous cell carcinoma reveals clinical relevance. Scientific Reports, November 2017. URL: http://dx.doi.org/10.1038/s41598-017-14909-5, doi:10.1038/s41598-017-14909-5. This article has 34 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-017-14909-5)

[2. (Fowler2018LIM) Sandy Fowler, Pascal Maguin, Sampada Kalan, and Diego Loayza. Lim protein ajuba associates with the rpa complex through direct cell cycle-dependent interaction with the rpa70 subunit. Scientific Reports, June 2018. URL: http://dx.doi.org/10.1038/s41598-018-27919-8, doi:10.1038/s41598-018-27919-8. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-018-27919-8)

[3. (Goyal1999Ajuba) Rakesh K. Goyal, Phoebe Lin, Josna Kanungo, Aimee S. Payne, Anthony J. Muslin, and Gregory D. Longmore. Ajuba, a novel lim protein, interacts with grb2, augments mitogen-activated protein kinase activity in fibroblasts, and promotes meiotic maturation of xenopus oocytes in a grb2- and ras-dependent manner. Molecular and Cellular Biology, 19(6):4379–4389, June 1999. URL: http://dx.doi.org/10.1128/mcb.19.6.4379, doi:10.1128/mcb.19.6.4379. This article has 83 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.19.6.4379)

[4. (Schleicher2021AJUBA:) Krista Schleicher and Daniel Schramek. Ajuba: a regulator of epidermal homeostasis and cancer. Experimental Dermatology, 30(4):546–559, January 2021. URL: http://dx.doi.org/10.1111/exd.14272, doi:10.1111/exd.14272. This article has 12 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1111/exd.14272)

[5. (Hirota2003AuroraA) Toru Hirota, Naoko Kunitoku, Takashi Sasayama, Tomotoshi Marumoto, Dongwei Zhang, Masayuki Nitta, Katsuyoshi Hatakeyama, and Hideyuki Saya. Aurora-a and an interacting activator, the lim protein ajuba, are required for mitotic commitment in human cells. Cell, 114(5):585–598, September 2003. URL: http://dx.doi.org/10.1016/s0092-8674(03)00642-1, doi:10.1016/s0092-8674(03)00642-1. This article has 497 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/s0092-8674(03)00642-1)

[6. (Ayyanathan2007The) Kasirajan Ayyanathan, Hongzhuang Peng, Zhaoyuan Hou, William J. Fredericks, Rakesh K. Goyal, Ellen M. Langer, Gregory D. Longmore, and Frank J. Rauscher. The ajuba lim domain protein is a corepressor for snag domain–mediated repression and participates in nucleocytoplasmic shuttling. Cancer Research, 67(19):9097–9106, October 2007. URL: http://dx.doi.org/10.1158/0008-5472.can-07-2987, doi:10.1158/0008-5472.can-07-2987. This article has 51 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/0008-5472.can-07-2987)

[7. (Zhang2017Mutations) Ming Zhang, Ratnakar Singh, Shaohua Peng, Tuhina Mazumdar, Vaishnavi Sambandam, Li Shen, Pan Tong, Lerong Li, Nene N. Kalu, Curtis R. Pickering, Mitchell Frederick, Jeffrey N. Myers, Jing Wang, and Faye M. Johnson. Mutations of the lim protein ajuba mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors. Cancer Letters, 392:71–82, April 2017. URL: http://dx.doi.org/10.1016/j.canlet.2017.01.024, doi:10.1016/j.canlet.2017.01.024. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.canlet.2017.01.024)

[8. (Kalan2013LIM) Sampada Kalan, Anastasiya Matveyenko, and Diego Loayza. Lim protein ajuba participates in the repression of the atr-mediated dna damage response. Frontiers in Genetics, 2013. URL: http://dx.doi.org/10.3389/fgene.2013.00095, doi:10.3389/fgene.2013.00095. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2013.00095)

[9. (Pratt2005The) Stephen J. Pratt, Holly Epple, Michael Ward, Yunfeng Feng, Vania M. Braga, and Gregory D. Longmore. The lim protein ajuba influences p130cas localization and rac1 activity during cell migration. The Journal of Cell Biology, 168(5):813–824, February 2005. URL: http://dx.doi.org/10.1083/jcb.200406083, doi:10.1083/jcb.200406083. This article has 98 citations.](https://doi.org/10.1083/jcb.200406083)

[10. (Feng2005The) Yungfeng Feng and Gregory D. Longmore. The lim protein ajuba influences interleukin-1-induced nf-κb activation by affecting the assembly and activity of the protein kinase cζ/p62/traf6 signaling complex. Molecular and Cellular Biology, 25(10):4010–4022, May 2005. URL: http://dx.doi.org/10.1128/mcb.25.10.4010-4022.2005, doi:10.1128/mcb.25.10.4010-4022.2005. This article has 63 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.25.10.4010-4022.2005)

[11. (Hou2010LIM) Zhaoyuan Hou, Hongzhuang Peng, David E. White, Dmitri G. Negorev, Gerd G. Maul, Yunfeng Feng, Gregory D. Longmore, Samuel Waxman, Arthur Zelent, and Frank J. Rauscher. Lim protein ajuba functions as a nuclear receptor corepressor and negatively regulates retinoic acid signaling. Proceedings of the National Academy of Sciences, 107(7):2938–2943, January 2010. URL: http://dx.doi.org/10.1073/pnas.0908656107, doi:10.1073/pnas.0908656107. This article has 43 citations.](https://doi.org/10.1073/pnas.0908656107)

[12. (Kanungo2000Ajuba) Jyotshnabala Kanungo, Stephen J. Pratt, Helene Marie, and Gregory D. Longmore. Ajuba, a cytosolic lim protein, shuttles into the nucleus and affects embryonal cell proliferation and fate decisions. Molecular Biology of the Cell, 11(10):3299–3313, October 2000. URL: http://dx.doi.org/10.1091/mbc.11.10.3299, doi:10.1091/mbc.11.10.3299. This article has 106 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1091/mbc.11.10.3299)